191 related articles for article (PubMed ID: 36756039)
21. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.
Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH
Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809
[TBL] [Abstract][Full Text] [Related]
22. Galantamine for Alzheimer's disease.
Olin J; Schneider L
Cochrane Database Syst Rev; 2002; (3):CD001747. PubMed ID: 12137632
[TBL] [Abstract][Full Text] [Related]
23. Chinese herbal medicine Qinggongshoutao for the treatment of amnestic mild cognitive impairment: A 52-week randomized controlled trial.
Tian J; Shi J; Wei M; Ni J; Fang Z; Gao J; Wang H; Yao H; Zhang J; Li J; Min M; Su L; Sun X; Wang B; Wang B; Yang F; Zou Y; Hu Y; Lin Y; Xu G; Li K; Li L; Zhen H; Xu J; Chen K; Wang Y;
Alzheimers Dement (N Y); 2019; 5():441-449. PubMed ID: 31517031
[TBL] [Abstract][Full Text] [Related]
24. A Two-Year Observational Study to Evaluate Conversion Rates from High- and Low-Risk Patients with Amnestic Mild Cognitive Impairment to Probable Alzheimer's Disease in a Real-World Setting.
Jang H; Na DL; Kwon JC; Jung NY; Moon Y; Lee JS; Park KW; Lee AY; Cho H; Lee JH; Kim BC; Park KH; Lee BC; Choi H; Kim J; Park MY
J Alzheimers Dis Rep; 2024; 8(1):851-862. PubMed ID: 38910942
[TBL] [Abstract][Full Text] [Related]
25. Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized, double-blind and parallel-controlled trial.
Miao YC; Tian JZ; Shi J; Mao M
Zhong Xi Yi Jie He Xue Bao; 2012 Apr; 10(4):390-7. PubMed ID: 22500712
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial.
Burns A; Bernabei R; Bullock R; Cruz Jentoft AJ; Frölich L; Hock C; Raivio M; Triau E; Vandewoude M; Wimo A; Came E; Van Baelen B; Hammond GL; van Oene JC; Schwalen S
Lancet Neurol; 2009 Jan; 8(1):39-47. PubMed ID: 19042161
[TBL] [Abstract][Full Text] [Related]
27. Cognition enhancing effect of panax ginseng in Korean volunteers with mild cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial.
Park KC; Jin H; Zheng R; Kim S; Lee SE; Kim BH; Yim SV
Transl Clin Pharmacol; 2019 Sep; 27(3):92-97. PubMed ID: 32055589
[TBL] [Abstract][Full Text] [Related]
28. ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension.
Gault LM; Lenz RA; Ritchie CW; Meier A; Othman AA; Tang Q; Berry S; Pritchett Y; Robieson WZ
Alzheimers Res Ther; 2016 Oct; 8(1):44. PubMed ID: 27756421
[TBL] [Abstract][Full Text] [Related]
29. Optimal dosing of galantamine in patients with mild or moderate Alzheimer's disease: post Hoc analysis of a randomized, double-blind, placebo-controlled trial.
Aronson S; Van Baelen B; Kavanagh S; Schwalen S
Drugs Aging; 2009; 26(3):231-9. PubMed ID: 19358618
[TBL] [Abstract][Full Text] [Related]
30. Metal protein attenuating compounds for the treatment of Alzheimer's dementia.
Sampson EL; Jenagaratnam L; McShane R
Cochrane Database Syst Rev; 2012 May; 5(5):CD005380. PubMed ID: 22592705
[TBL] [Abstract][Full Text] [Related]
31. The effects of low-dose radiation therapy in patients with mild-to-moderate Alzheimer's dementia: an interim analysis of a pilot study.
Kim A; Lee J; Moon H; Kim C; Yoo MY; Park WY; Kim WD; Seo YS
Radiat Oncol J; 2023 Jun; 41(2):89-97. PubMed ID: 37403351
[TBL] [Abstract][Full Text] [Related]
32. Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial.
Wade AG; Farmer M; Harari G; Fund N; Laudon M; Nir T; Frydman-Marom A; Zisapel N
Clin Interv Aging; 2014; 9():947-61. PubMed ID: 24971004
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials.
Wessels AM; Tariot PN; Zimmer JA; Selzler KJ; Bragg SM; Andersen SW; Landry J; Krull JH; Downing AM; Willis BA; Shcherbinin S; Mullen J; Barker P; Schumi J; Shering C; Matthews BR; Stern RA; Vellas B; Cohen S; MacSweeney E; Boada M; Sims JR
JAMA Neurol; 2020 Feb; 77(2):199-209. PubMed ID: 31764959
[TBL] [Abstract][Full Text] [Related]
34. Cognitive improvement effects of Tian Wang Bu Xin Dan (Cheonwangbosimdan) in patients with mild cognitive impairment: protocol for a randomized placebo-controlled pilot clinical trial.
Kim JH; Cho MR; Yoo J; Park GC; Lee JS
Ann Palliat Med; 2022 Oct; 11(10):3320-3329. PubMed ID: 36267013
[TBL] [Abstract][Full Text] [Related]
35. The effect of cognitive training in patients with mild cognitive impairment and early Alzheimer's disease: a preliminary study.
Hwang HR; Choi SH; Yoon DH; Yoon BN; Suh YJ; Lee D; Han IT; Hong CG
J Clin Neurol; 2012 Sep; 8(3):190-7. PubMed ID: 23091528
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study.
Florian H; Meier A; Gauthier S; Lipschitz S; Lin Y; Tang Q; Othman AA; Robieson WZ; Gault LM
J Alzheimers Dis; 2016; 51(4):1237-47. PubMed ID: 26967214
[TBL] [Abstract][Full Text] [Related]
37. Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial.
Lannfelt L; Blennow K; Zetterberg H; Batsman S; Ames D; Harrison J; Masters CL; Targum S; Bush AI; Murdoch R; Wilson J; Ritchie CW;
Lancet Neurol; 2008 Sep; 7(9):779-86. PubMed ID: 18672400
[TBL] [Abstract][Full Text] [Related]
38. An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer's disease.
Kainuma M; Ouma S; Kawakatsu S; Iritani O; Yamashita KI; Ohara T; Hirano S; Suda S; Hamano T; Hieda S; Yasui M; Yoshiiwa A; Shiota S; Hironishi M; Wada-Isoe K; Sasabayashi D; Yamasaki S; Murata M; Funakoshi K; Hayashi K; Shirafuji N; Sasaki H; Kajimoto Y; Mori Y; Suzuki M; Ito H; Ono K; Tsuboi Y
Front Pharmacol; 2022; 13():991982. PubMed ID: 36313371
[No Abstract] [Full Text] [Related]
39. Effectiveness of Yi-Zhi-An-Shen granules on cognition and sleep quality in older adults with amnestic mild cognitive impairment: protocol for a randomized, double-blind, placebo-controlled trial.
Yue S; He T; Li B; Qu Y; Peng H; Chen J; Lei M; Chen C; Wu W
Trials; 2019 Aug; 20(1):518. PubMed ID: 31429790
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
